SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-027262
Filing Date
2024-02-26
Accepted
2024-02-26 07:06:50
Documents
16
Period of Report
2024-02-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm247232d1_8k.htm   iXBRL 8-K 26838
2 EXHIBIT 99.1 tm247232d1_ex99-1.htm EX-99.1 15728
6 GRAPHIC tm247232d1_ex99-1img001.jpg GRAPHIC 13698
  Complete submission text file 0001104659-24-027262.txt   239250

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mist-20240226.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mist-20240226_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mist-20240226_pre.xml EX-101.PRE 22373
18 EXTRACTED XBRL INSTANCE DOCUMENT tm247232d1_8k_htm.xml XML 3847
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 24673526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)